Selecta Biosciences, Inc. (SELB)
(Delayed Data from NSDQ)
$2.35 USD
+0.23 (10.85%)
Updated May 3, 2019 04:00 PM ET
After-Market: $2.36 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For SELB
-
Selecta Biosciences, Inc. (SELB) Reports Q2 Loss, Misses Revenue Estimates
-
Selecta Biosciences Reports Second Quarter 2023 Financial Results and Updates on Strategic Initiative Designed to Maximize Stockholder Value Associated with SEL-212 Economics
-
Selecta Biosciences, Inc. (SELB) Reports Q1 Loss, Misses Revenue Estimates
-
Selecta Biosciences Reports First Quarter 2023 Financial Results and Provides Business Update
-
Selecta Biosciences, Inc. (SELB) Reports Q4 Loss, Tops Revenue Estimates
-
Selecta Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
-
Selecta Biosciences, Inc. (SELB) Reports Q3 Loss, Lags Revenue Estimates
-
Selecta Biosciences Reports Third Quarter 2022 Financial Results and Provides Business Update
-
Selecta Biosciences, Inc. (SELB) Q2 Earnings and Revenues Surpass Estimates
-
Selecta Biosciences, Inc. (SELB) Reports Q1 Loss, Tops Revenue Estimates
-
Selecta Biosciences, Inc. (SELB) Reports Q4 Loss, Tops Revenue Estimates
-
Selecta Biosciences, Inc. (SELB) Reports Q3 Loss, Tops Revenue Estimates
-
Selecta Biosciences, Inc. (SELB) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
-
Selecta Biosciences, Inc. (SELB) Reports Q2 Loss, Tops Revenue Estimates
-
Selecta Biosciences, Inc. (SELB) Reports Q1 Loss, Tops Revenue Estimates
-
Selecta Biosciences, Inc. (SELB) Reports Q4 Loss, Tops Revenue Estimates
-
Selecta Biosciences, Inc. (SELB) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
-
Selecta's (SELB) Q3 Loss Narrower-Than Expected, Revenues Beat
-
What's in Store for Selecta (SELB) This Earnings Season?
-
Selecta Biosciences, Inc. (SELB) Reports Q2 Loss, Lags Revenue Estimates
-
Selecta Biosciences (SELB) Q2 Earnings & Sales Miss Estimates
-
What Awaits Selecta Biosciences (SELB) This Earnings Season?
-
Increased Earnings Estimates Seen for Selecta Biosciences (SELB): Can It Move Higher?